PLA2G4A and COVID-19: Current clinical studies have shown that the expression levels of inflammatory factors (IL-2, IL-7, IFN-γ, and TNF-α) positively correlate with the severity of COVID-19 (Huang et al., 2020), suggesting that PLA2G4A may be a key target in the development of COVID-19.